Invectys Therapeutics
Nicolas Duthoit is an experienced communication and business development professional with a background in life sciences. Currently serving as Communication Project Manager at Invectys since January 2019, Nicolas has previously held the position of Business Development Analyst at Voisin Consulting Life Sciences from February 2015 to December 2017, where responsibilities included coordinating thought leadership strategies and managing client proposals. Prior experience also includes an internship as Manager Assistant at BioAlliance Pharma, focusing on product launch in the USA, and an internship at U.S. Commercial Service, aiding in the establishment of commercial partnerships. Nicolas obtained a degree from Institut Sup'Biotech Paris, completing studies in 2015.
This person is not in any teams
This person is not in any offices
Invectys Therapeutics
Invectys is a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancers. It was founded in 2010 by Pierre Langlade Demoyen and Simon Wayne-Hobson and is based in Paris.Invectys develops a novel approach to mobilizing and restoring the anti-tumor capacity of the immune system of cancer patients.This allows virtually all cancers to be targeted. Invectys focuses its efforts on two highly prevalent tumor antigens: the nearly-universal tumor antigen telomerase that is critical to uncontrolled cell growth, and the HLA-G immune checkpoint expressed in over 50% of cancers.